Cargando…

LAPTM5 Restricts HIV-1 Infection in Dendritic Cells and Is Counteracted by Vpr

Detalles Bibliográficos
Autores principales:	Ouyang, Jiayue, Xiong, Ying, Shang, Hong, Liang, Guoxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045178/ https://www.ncbi.nlm.nih.gov/pubmed/35225654 http://dx.doi.org/10.1128/spectrum.01382-21

Ejemplares similares

Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages
por: Zhao, Li, et al.
Publicado: (2021)

Mannose receptor is an HIV restriction factor counteracted by Vpr in macrophages
por: Lubow, Jay, et al.
Publicado: (2020)

HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells
por: Yan, Junpeng, et al.
Publicado: (2019)

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane
por: Pang, Hailin, et al.
Publicado: (2023)

Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
por: Pak, Youngshil, et al.
Publicado: (2006)

Vpr Is a VIP: HIV Vpr and Infected Macrophages Promote Viral Pathogenesis
por: Lubow, Jay, et al.
Publicado: (2020)

HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing
por: Forouzanfar, F., et al.
Publicado: (2019)

HIV-1 Vpr and p21 restrict LINE-1 mobility
por: Kawano, Koudai, et al.
Publicado: (2018)

Primate immunodeficiency virus Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex
por: Yurkovetskiy, Leonid, et al.
Publicado: (2018)

Down-regulation of LAPTM5 in human cancer cells
por: Nuylan, Michelle, et al.
Publicado: (2016)

SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef
por: Usami, Yoshiko, et al.
Publicado: (2015)

Localization of HIV-1 Vpr to the nuclear envelope: Impact on Vpr functions and virus replication in macrophages
por: Jacquot, Guillaume, et al.
Publicado: (2007)

Differential Effects of Vpr on Single-cycle and Spreading HIV-1 Infections in CD4(+) T-cells and Dendritic Cells
por: de Silva, Suresh, et al.
Publicado: (2012)

Illuminating the Role of Vpr in HIV Infection of Myeloid Cells
por: Nodder, Sarah Beth, et al.
Publicado: (2019)

LAPTM5 is transactivated by RUNX2 and involved in RANKL trafficking in osteoblastic cells
por: Geng, Yuan-Ming, et al.
Publicado: (2019)

LAPTM5–CD40 Crosstalk in Glioblastoma Invasion and Temozolomide Resistance
por: Berberich, Anne, et al.
Publicado: (2020)

HIV-1 Vpr—a still “enigmatic multitasker”
por: Guenzel, Carolin A., et al.
Publicado: (2014)

Counteraction of inflammatory activity in CAA-related subarachnoid hemorrhage
por: Schreiber, Stefanie, et al.
Publicado: (2022)

Centrosome amplification and aneuploidy driven by the HIV-1-induced Vpr•VprBP•Plk4 complex in CD4(+) T cells
por: Park, Jung-Eun, et al.
Publicado: (2023)

Vpr makes holes
por: Wells, William A.
Publicado: (2001)

Characterization of the Molecular Determinants of Primary HIV-1 Vpr Proteins: Impact of the Q65R and R77Q Substitutions on Vpr Functions
por: Jacquot, Guillaume, et al.
Publicado: (2009)

The “Italian way” to counteract obstructive sleep apnoea syndrome in children
por: Villa, M. P., et al.
Publicado: (2018)

Molecule of the month: HIV-1 protein Vpr and miRNA
por: Shapshak, Paul
Publicado: (2012)

LAPTM4B promotes the progression of nasopharyngeal cancer
por: Su, Qun, et al.
Publicado: (2021)

Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4(+) T Lymphocytes
por: Collins, David R., et al.
Publicado: (2015)

The SMC5/6 complex compacts and silences unintegrated HIV-1 DNA and is antagonized by Vpr
por: Dupont, Liane, et al.
Publicado: (2021)

HIV-1 Vpr Reprograms CLR4(DCAF1) E3 Ubiquitin Ligase to Antagonize Exonuclease 1-Mediated Restriction of HIV-1 Infection
por: Yan, Junpeng, et al.
Publicado: (2018)

Effect on HIV-1 Gene Expression, Tat-Vpr Interaction and Cell Apoptosis by Natural Variants of HIV-1 Tat Exon 1 and Vpr from Northern India
por: Lata, Sneh, et al.
Publicado: (2013)

Vpr loosens chromatid ties
por: Short, Ben
Publicado: (2011)

Lysosomal-Associated Protein Multispanning Transmembrane 5 Gene (LAPTM5) Is Associated with Spontaneous Regression of Neuroblastomas
por: Inoue, Jun, et al.
Publicado: (2009)

Lysosomal-Associated Transmembrane Protein 5 (LAPTM5) Is a Molecular Partner of CD1e
por: Angénieux, Catherine, et al.
Publicado: (2012)

Adaptation to hypobaric hypoxia of residents at high altitude, to counteract COVID-19 disease()
por: Canales-Gutiérrez, Angel, et al.
Publicado: (2021)

Combination Therapy with CCBs and RAS Inhibitors to Counteract Endothelial Dysfunction in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2022)

Characterization of HIV-1 Vpr Nuclear Import: Analysis of Signals and Pathways
por: Jenkins, Yonchu, et al.
Publicado: (1998)

Regulation of the HIV-1 promoter by HIF-1α and Vpr proteins
por: Deshmane, Satish L, et al.
Publicado: (2011)

The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention
por: González, María Eugenia
Publicado: (2017)

miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP
por: Ma, Li, et al.
Publicado: (2014)

Evolutionary Toggling of Vpx/Vpr Specificity Results in Divergent Recognition of the Restriction Factor SAMHD1
por: Fregoso, Oliver I., et al.
Publicado: (2013)

HIV-1 Vpr Induces the Degradation of ZIP and sZIP, Adaptors of the NuRD Chromatin Remodeling Complex, by Hijacking DCAF1/VprBP
por: Maudet, Claire, et al.
Publicado: (2013)

HIV-1 Accessory Protein Vpr: Relevance in the pathogenesis of HIV and potential for therapeutic intervention
por: Kogan, Michael, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9dp7voa0a22tjn7mkcs5sbi520